AlzeCure to present promising pain therapy ACD440 at NeuPSIG 2025

21st July 2025 Uncategorised 0

Clinical results from phase 2 study highlight analgesic effects in neuropathic pain patients

More: AlzeCure to present promising pain therapy ACD440 at NeuPSIG 2025
Source: News